Jill Adler-Moore
Affiliations: | Biology | California State Polytechnic University, Pomona |
Google:
"Jill Adler-Moore"Children
Sign in to add trainee| Scott A. Wetzel | grad student | 1988-1992 | California State Polytechnic University, Pomona |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wasmann RE, Smit C, van Dongen EPH, et al. (2019) Fixed Dosing of Liposomal Amphotericin B in Morbidly Obese Individuals. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America |
| Adler-Moore J, Lewis RE, Brüggemann RJM, et al. (2019) Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 68: S244-S259 |
| Groll AH, Rijnders BJA, Walsh TJ, et al. (2019) Clinical Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of Liposomal Amphotericin B. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 68: S260-S274 |
| Walsh TJ, Lewis RE, Adler-Moore J. (2019) Pharmacology of Liposomal Amphotericin B: An Introduction to Preclinical and Clinical Advances for Treatment of Life-threatening Invasive Fungal Infections. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 68: S241-S243 |
| Dave JJ, Sandoval A, Olson J, et al. (2019) 1577. Particle Characterization of Nebulized Liposomal Amphotericin B and Its Use in the Treatment of Murine Pulmonary Aspergillosis Open Forum Infectious Diseases. 6 |
| Sandoval A, Adler-Moore J. (2019) 1554. Nebulized Liposomal Amphotericin B for Treatment of Murine Pulmonary Mucormycosis Open Forum Infectious Diseases. 6 |
| Olson J, Slarve M, Adler-Moore J. (2018) 1639. Efficacy of Voriconazole Prophylaxis Followed by Therapeutic Liposomal Amphotericin B for the Treatment of Murine Pulmonary Aspergillosis Caused by Azole-Resistant Aspergillus fumigatus Strains Open Forum Infectious Diseases. 5 |
| Adler-Moore JP, Gangneux JP, Pappas PG. (2016) Comparison between liposomal formulations of amphotericin B. Medical Mycology. 54: 223-31 |
| Smith PJ, Olson JA, Constable D, et al. (2007) Effects of dosing regimen on accumulation, retention and prophylactic efficacy of liposomal amphotericin B. The Journal of Antimicrobial Chemotherapy. 59: 941-51 |
| Spellberg B, Schwartz J, Fu Y, et al. (2006) Comparison of antifungal treatments for murine fusariosis. The Journal of Antimicrobial Chemotherapy. 58: 973-9 |